NCT01110304

Brief Summary

Acromio-clavicular (AC) joint dislocation corresponds to 8.6% of all joint dislocations and represents a major injury to the shoulder girdle. The nature of the treatment is decided according to the severity of the lesion. The purpose of this study is to determine whether the surgical treatment is required or not for type III AC joint dislocations.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 26, 2010

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

December 20, 2012

Status Verified

December 1, 2012

Enrollment Period

5.8 years

First QC Date

April 21, 2010

Last Update Submit

December 19, 2012

Conditions

Keywords

acromio-clavicular joint dislocationtype III acromio-clavicular joint dislocationjoint dislocationclavicle hook plate

Outcome Measures

Primary Outcomes (1)

  • Functional results of injured shoulder on Constant score

    Based on the patient's subjective and objective answers to the Constant and Murley questionnaire, data are collected and calculated over a 100 points to measure the functional score of the injured shoulder. Also, to measure shoulder strength, the Isoforce system from MDS® is used.

    3 months after surgery

Secondary Outcomes (12)

  • Return to professional activities

    3 months after surgery

  • Rate of secondary surgery

    up to 12 months after surgery

  • Social impact on SF-36 scale

    3 months after surgery

  • Functional difference

    6 months after surgery

  • Social impact on SF-36 scale

    6 months after surgery

  • +7 more secondary outcomes

Study Arms (2)

Conservative treatment

ACTIVE COMPARATOR

Patients selected for this treatment will wear a light brace for pain release and analgesics will be prescribed.

Other: Conservative treatment - brace

Surgical treatment

ACTIVE COMPARATOR

Patients will undergo surgery to treat their AC joint dislocation.

Device: Hook plate by Synthes

Interventions

Patients selected for this treatment will wear a light brace for pain release and analgesics will be prescribed. They can move the elbow, the wrist and the fingers immediately. After two weeks, they will begin a training program to restore shoulder motion and strength, and they will be asked to take off the brace progressively. They are allowed to start working and sporting activities when they feel comfortable.

Also known as: brace and analgesics
Conservative treatment

The patient is in a beach-chair position with injured arm slightly out of the table, on a bracket. The incision is longitudinal, from the distal third of the clavicle to the lateral border of the acromion. The deltoid is detached anteriorly to present the clavicle and the AC joint. The width of the hook depends on the depth of the acromion. The plate will always be 5 holes 3.5mm hook plate (Synthes®), left or right. The hook is inserted after visual reduction of the AC joint at the posterior border of the distal end of the clavicle, under the acromion. Reduction is then maintained by a davier and fixation with three 3,5mm cortical screws is achieved. After washing, deltoid is reinserted. CC ligaments are not directly repaired. Wound closure and bracing for two weeks.

Also known as: hook plate surgery
Surgical treatment

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • men or women ≥ 18 years-old;
  • AC joint dislocation type III with Zanca X-ray view demonstrating CC distance of 200%;
  • trauma-surgery delay of less than 14 days;
  • consent form signed.

You may not qualify if:

  • AC joint dislocation type I, II, IV, V or VI;
  • associated neuro-vascular damage;
  • men or women \> 60 years-old;
  • open dislocation;
  • local skin damage;
  • dislocation in a polytrauma patient;
  • floating shoulder;
  • fracture of the ipsilateral or controlateral arm or shoulder girdle;
  • fracture of the coracoid process of the scapula;
  • history of previous surgery to the shoulder;
  • medical condition preventing surgery;
  • men or women unfit to consent;
  • any other condition that make the examinator thinks that the follow up would be problematic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHA-Pavillon Enfant-Jésus

Québec, Quebec, G1J 1Z4, Canada

RECRUITING

MeSH Terms

Conditions

Joint Dislocations

Interventions

BracesAnalgesics

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Orthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesSensory System AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Stéphane Pelet, MD, PhD

    Hôpital Enfant-Jésus

    PRINCIPAL INVESTIGATOR
  • Karine Sinclair, MD, FRCSC

    Hôpital Enfant-Jésus

    PRINCIPAL INVESTIGATOR
  • Luc Bédard, MD, FRCSC

    Hôpital Enfant-Jésus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hélène Côté, Reg. Nurse

CONTACT

Stéphane Pelet, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Stephane Pelet MD, PhD Orthopedic surgeon

Study Record Dates

First Submitted

April 21, 2010

First Posted

April 26, 2010

Study Start

May 1, 2007

Primary Completion

February 1, 2013

Study Completion

February 1, 2015

Last Updated

December 20, 2012

Record last verified: 2012-12

Locations